Farther Finance Advisors’s Pliant Therapeutics PLRX Stock Holding History

Farther Finance Advisors’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5	Hold	5	–	–	﹤0.01%	6116
2026 Q2	$6	Hold	5	–	–	﹤0.01%	5944
2026 Q1	$7	Hold	5	–	–	﹤0.01%	5704
2025 Q4	$6	Hold	5	–	–	﹤0.01%	5425
2025 Q3	$7	Hold	5	–	–	﹤0.01%	4931
2025 Q2	$6	Hold	5	–	–	﹤0.01%	4466
2025 Q1	$7	Sell	5 -1	-17%	-$6	﹤0.01%	4231
2024 Q4	$79	Hold	6	–	–	﹤0.01%	3819
2024 Q3	$67	Hold	6	–	–	﹤0.01%	3837
2024 Q2	$65	Hold	6	–	–	﹤0.01%	3661
2024 Q1	$89	Hold	6	–	–	﹤0.01%	3398
2023 Q4	$109	Buy	+6	New	+$91	﹤0.01%	3293

Farther Finance Advisors's PLRX Position: Q3 2026 in Review

Farther Finance Advisors held its Pliant Therapeutics (PLRX) position steady in Q3 2026 at 5 shares worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #6116.

Farther Finance Advisors first reported a position in PLRX in Q4 2023 and has held it in 12 quarters since. The position peaked at $109 in Q4 2023. 1 fund tracked by Wall St. Rank holds PLRX as of Q3 2026.

Farther Finance Advisors held 5 shares of Pliant Therapeutics worth $5 as of Q3 2026.
Farther Finance Advisors left its Pliant Therapeutics share count unchanged in Q3 2026.
Pliant Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #6116 holding.
Farther Finance Advisors first reported a position in Pliant Therapeutics in Q4 2023 and has held it in 12 quarters since.
Farther Finance Advisors's Pliant Therapeutics position peaked at $109 in Q4 2023.
1 fund tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.